Patients at the James Graham Brown Cancer Center are often among the first in the world to have access to promising new therapies through leading-edge clinical trials.
Key initiatives have been developed to increase the number of clinical trials available to patients, to raise the percentage of patients participating in clinical trials, and to ensure that clinical trials are available in all the clinics. Learn more about clinical trials.
4 matches found
- 11.0365Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer (Study # RTOG 1016)
- 12.0220Preliminary Clinical Trial Investigating the Ability of Plant Exosomes to Abrogate Oral Mucositis Induced by Combined Chemotherapy and Radiation in Head and Neck Cancer Patients (Study # BCC-OHN-11)
- 11.0144A Randomized Phase II Study of Concurrent Intensity Modulated Radiation Therapy (IMRT), Paclitaxel and Pazopanib (NSC 737754)/Placebo, for the Treatment of Anaplastic Thyroid Cancer (RTOG 0912)
- 10.0151A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer (Study # RTOG 0920)
- Previous Page
- Next Page